Prognostic value of PIK3CA gene assessment in tissue & plasma in metastatic colorectal cancer (mCRC)

被引:0
|
作者
Brage, E. Teran [1 ]
Tocino, R. Vidal [1 ]
Puertas, P. Reguera [1 ]
Mateos, Y. Lopez [1 ]
Gutierrez, A. Lopez [1 ]
Hernandez, M. M. Abad [2 ]
Manzano, J. Sayagues [2 ]
Rodrigues, A. [1 ]
Montero-Gonzalez, J. [2 ]
Araujo, D. Morchon [1 ]
Gonzalez, J. C. Redondo [1 ]
Mejorada, R. Lozano [1 ]
Sanchez, E. Fonseca [1 ]
机构
[1] Univ Hosp Salamanca, Med Oncol Dept, Salamanca, Spain
[2] Univ Hosp Salamanca, Dept Pathol, Salamanca, Spain
关键词
D O I
10.1016/j.annonc.2024.05.116
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
105P
引用
收藏
页码:S49 / S49
页数:1
相关论文
共 50 条
  • [1] Role of RAS/BRAF and PIK3CA mutations in tissue and plasma for prognostic assessment in metastatic colorectal cancer (mCRC).
    Teran-Brage Sr, Eduardo
    Lopez-Mateos, Yolanda
    Abad Hernandez, Maria Mar
    Sayagues-Manzano, Jose Maria
    Francoso, Aline Rodrigues
    Diaz-Sanchez, Pablo
    Fonseca-Sanchez Sr, Emilio
    Vidal-Tocino, Rosario
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 281 - 281
  • [2] Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer
    Tan, Elaine S.
    Fan, Wenyi
    Knepper, Todd C.
    Schell, Michael J.
    Sahin, Ibrahim H.
    Fleming, Jason B.
    Xie, Hao
    TARGETED ONCOLOGY, 2022, 17 (04) : 483 - 492
  • [3] Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer
    Elaine S. Tan
    Wenyi Fan
    Todd C. Knepper
    Michael J. Schell
    Ibrahim H. Sahin
    Jason B. Fleming
    Hao Xie
    Targeted Oncology, 2022, 17 : 483 - 492
  • [4] Prognostic and predictive value of PIK3CA mutations in metastatic CRC (mCRC)
    Tan, Elaine
    Fan, Wenyi
    Schell, Michael
    Sahin, Ibrahim
    Fleming, Jason
    Knepper, Todd
    Xie, Hao
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Comment on: "Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer"
    Han, Wei
    Hu, Yong-wei
    Lu, Wei-jie
    Wang, Hao-nan
    TARGETED ONCOLOGY, 2024, 19 (04) : 661 - 662
  • [6] Molecular, clinical and prognostic characterization of double KRAS/PIK3CA (dKP) mutated metastatic colorectal cancer (mCRC)
    Grasselli, J.
    Elez, E.
    Argiles Martinez, G.
    Sanz-Garcia, E.
    Macarulla, T.
    Capdevila, J.
    Alsina, M.
    Sauri, T.
    Hierro, C.
    Verdaguer, H.
    Matos, I.
    Garcia, A.
    Nuciforo, P.
    Landolfi, S.
    Garcia Palmer, H.
    Dienstmann, R.
    Vivancos, A.
    Tabernero, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [7] Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer
    Stec, Rafal
    Semeniuk-Wojtas, Aleksandra
    Charkiewicz, Radoslaw
    Bodnar, Lubomir
    Korniluk, Jan
    Smoter, Marta
    Chyczewski, Lech
    Niklinski, Jacek
    Szczylik, Cezary
    ONCOLOGY LETTERS, 2015, 10 (03) : 1423 - 1429
  • [8] PIK3CA mutation in metastatic colorectal cancer (mCRC): Association with clinico-pathological features and outcome
    Fanotto, V.
    Zucchelli, G.
    Germani, M. M.
    Rossini, D.
    Sensi, E.
    Lupi, C.
    Ugolini, C.
    Antoniotti, C.
    Marmorino, F.
    Moretto, R.
    Boccaccino, A.
    Borelli, B.
    Conca, V.
    Ongaro, E.
    Masi, G.
    Fontanini, G.
    Falcone, A.
    Cremolini, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] PIK3CA in colorectal cancer
    Cathomas, Gieri
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [10] The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
    Eklof, V.
    Wikberg, M. L.
    Edin, S.
    Dahlin, A. M.
    Jonsson, B-A
    Oberg, A.
    Rutegard, J.
    Palmqvist, R.
    BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 2153 - 2163